Natixis’s Immunogen Inc IMGN Stock Holding History

Natixis’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-75,000	Closed	-$1.19M	–	1209
2023 Q3	$1.19M	Buy	+75,000	New	+$1.25M	0.01%	476
2017 Q4	–	Sell	-10,541	Closed	-$81K	–	1240
2017 Q3	$81K	Buy	+10,541	New	+$70K	﹤0.01%	1196

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Natixis's IMGN Position: Q4 2023 in Review

Natixis sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 75,000 shares — an estimated $1.19M sold.

Natixis first reported a position in IMGN in Q3 2017 and held it in 2 quarters. The position peaked at $1.19M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Natixis reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Natixis sold 75,000 Immunogen Inc shares in Q4 2023, an estimated $1.19M.
Natixis first reported a position in Immunogen Inc in Q3 2017 and held it in 2 quarters.
Natixis's Immunogen Inc position peaked at $1.19M in Q3 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Natixis's 13F filing for Q4 2023, filed 13 Feb 2024.